About us
CREACT Consulting
supports life sciences companies developing innovative new drugs in paving the way for regulatory approvals throughout their clinical development journey. We help companies navigate complex regulatory landscapes, optimize their overall regulatory strategies and get the CMC development to the point, altogether with one key objective: to streamline drug development. By focusing our services from early development to late-stage clinical development (excluding the marketing stage), CREACT Consulting offers in-depth expertise and phase-appropriate support.
Our philosophy
Innovation and speed through actions that matter are our two guiding principles ; CREACT embodies the fusion of CREATE and ACT.
Our Values
CREACT Consulting is built on values that guide our work and culture.
Team
We work as one team with our clients, building trust and tailoring our services to their needs.
Commitment
We ethically support companies that create life-saving products, making a positive impact.
Excellence
We strive for excellence, always seeking improvement in everything we do
Science-driven
We challenge regulations with data, embracing change, innovation, and scientific rigor.
Discover What We Do
We offer comprehensive regulatory services and sharp regulatory CMC expertise to partner with you, from early discovery to late-stage clinical development
Discover Our Services
Meet Céline Tellier, PhD, Managing Director
Céline is the founder of CREACT Consulting, bringing nearly a decade of experience in the biopharmaceutical industry as a seasoned expert in Regulatory Affairs and Chemistry, Manufacturing, and Controls (CMC). Prior to founding CREACT Consulting, Céline led the CMC & Regulatory team at Exothera, a CDMO specializing in viral vectors and mRNA manufacturing for vaccines and gene therapies. Her leadership extended beyond technical execution; she built the company’s CMC and Regulatory function from the ground up, structured regulatory roadmaps, and provided strategic guidance on process characterization, product comparability, and control strategies.
Before joining Exothera, Céline worked as a Regulatory Affairs Consultant at RLM Consulting, where she supported multiple biotech companies in defining regulatory milestones, developing preclinical and CMC plans, authoring core documents (Investigator’s Brochure, IMPD / Module 3 CTD) for clinical trial applications, and engaging with regulatory agencies such as EMA, FDA and European National Competent Authorities. There, she gained hands-on expertise in authoring and submitting regulatory dossiers for a diverse range of product including cell and gene therapies, vaccines and recombinant proteins for therapeutic applications.
Céline holds a Master’s in Biochemistry and Cellular Biology and a PhD in Cell Biology from the University of Namur (Belgium), with research expertise in cancer biology and immunology. Her solid scientific knowledge enables her to bring a strong analytical mindset, regulatory acumen, risk-mitigation approach and strategic vision to help life sciences companies successfully advance their products through late-stage clinical development.